A scientist pipetting at a biomedical laboratory on 9 August, 2018. Photo: ALAMY
Andrew Langer
Opinion

Opinion

Macroscope by Andrew Langer

Indonesia’s policy misstep is Vietnam’s opportunity to seize the sweet spot as Southeast Asia’s pharmaceutical hub

  • Indonesia is actively driving out biopharmaceutical and other sophisticated ventures, requiring the compulsory licensing of any non-indigenous pharmaceutical products
  • This intellectual property grab will result in the list of drugs not available in Indonesia to grow even longer

TOP PICKS

A scientist pipetting at a biomedical laboratory on 9 August, 2018. Photo: ALAMY
READ FULL ARTICLE